Page last updated: 2024-11-02

moxonidine and Pre-Eclampsia

moxonidine has been researched along with Pre-Eclampsia in 1 studies

moxonidine: structure given in first source

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research Excerpts

ExcerptRelevanceReference
"Optimal cardiovascular prevention after preeclampsia should be further explored."3.11Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study). ( Franx, A; Groenhof, TKJ; Paauw, ND; Spiering, W; Titia Lely, A; Veerbeek, JHW; Verhaar, MC; Zoet, GA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zoet, GA1
Paauw, ND1
Veerbeek, JHW1
Groenhof, TKJ1
Spiering, W1
Verhaar, MC1
Franx, A1
Titia Lely, A1

Trials

1 trial available for moxonidine and Pre-Eclampsia

ArticleYear
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-controlled cross-over trial (the PALM study).
    Pregnancy hypertension, 2022, Volume: 27

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Cross-Over

2022